OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 26, 2020
A study to be presented at the annual meeting of the Radiological Society of North America reported that COVID-19 patients with diabetes and hypertension may have a higher risk for neurologic complications.
November 25, 2020
As coronavirus disease 2019 (COVID-19) cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.
November 23, 2020
Infectious Disease Society of America offered a look at the current treatment options for COVID-19 and stressed the need to maintain precautions to keep people safe.
One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.
November 20, 2020
Here's the roundup of this week's coronavirus-related news.
Results from the NIAID-sponsored ACTT-2 trial showed that COVID-19 patients treated with baricitinib in combination with remdesivir experienced better recovery times and clinical status.
Pfizer and BioNTech expect to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021.
November 19, 2020
Officials with Operation Warp Speed said distribution of a COVID-19 vaccine will begin within 24 hours after FDA authorization.
November 18, 2020
Pfizer and BioNTech today announced that their COVID-19 vaccine candidate showed a 95% efficacy rate in the final analysis of its phase 3 study.
November 16, 2020
Moderna announced today that its messenger RNA vaccine candidate for COVID-19 met the primary endpoint of efficacy, according to the study’s first interim analysis.
November 13, 2020
Here’s a roundup of the latest coronavirus-related news.
As part of a new partnership with HHS, the nation’s largest pharmacy chains—as well as independents and regional chains—will be administering free coronavirus disease 2019 (COVID-19) vaccines when they are available.
November 11, 2020
The FDA has granted Fast Track Designation for NVX-CoV2373, a vaccine candidate for COVID-19.
November 10, 2020
The FDA has authorized Lilly’s investigational neutralizing antibody for COVID-19 treatment in the outpatient setting.
November 09, 2020
Interim analysis results from a phase 3 clinical trial reported a vaccine efficacy rate above 90% for BNT162b2. The trial is ongoing until it meets its threshold for confirmed COVID-19 cases.
November 06, 2020
Here's the coronavirus-related news from this week.
November 05, 2020
Guest host Brian Nightengale, president of Good Neighbor Pharmacy, is joined by Rich Tremonte and Doug Hoey to discuss the biggest opportunities and headwinds facing independent pharmacies in 2021.
November 04, 2020
MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects."
November 03, 2020
Members of the MJH COVID-19 Coalition were surveyed about strategies for pandemic containment.
The UK study examined the cross-sectional association between vitamins A, E, C, and D and respiratory complaints.